Erectile dysfunction treatment chart including onset time, duration of action, and dosing for each drug product.
Risk factors for overactive bladder and urinary incontinence chart in men and women.
A study found no survival differences between high-grade UTUC patients who at the time of radical nephroureterectomy achieved low-grade disease following neoadjuvant chemotherapy and those who had inherently low-stage disease and did not receive chemotherapy.
ASCO officials examined the discrepancies in financial disclosures across platforms and call for a simplified system.
Padcev is the first antibody-drug conjugate approved for advanced urothelial cancer patients.